RBE Cells
€750.00*
Products are shipped frozen on dry ice in cryotubes. Each cryotube typically contains 3 × 106 cells for adherent lines or 5 × 106 cells for suspension lines (refer to the batch CoA for details).
General information
| Description | The RBE cell line is a human intrahepatic cholangiocarcinoma (CC) cell line derived from a 64-year-old female patient. This cell line was established alongside a sarcomatoid counterpart (SSP-25) from the same tumor nodule, highlighting the coexistence of adenocarcinoma and sarcomatoid components within a single CC lesion. RBE cells are characterized by their epithelial morphology, growing as a monolayer with a Epithelial-like appearance, which is typical of epithelial cells. Phenotypically, the RBE cell line expresses key markers associated with cholangiocarcinoma. These include cytokeratins CK7 and CK19, gamma-glutamyl transpeptidase (GGT), carcinoembryonic antigen (CEA), carbohydrate antigen 19-9 (CA19-9), and vimentin. Additionally, mucin production is detected in approximately half of the RBE cells, as evidenced by periodic acid-Schiff (PAS) staining. These features confirm the adenocarcinoma origin of RBE cells and distinguish them from the SSP-25 cell line, which lacks CEA, CA19-9, and mucin expression. |
|---|---|
| Organism | Human |
| Tissue | Bile duct |
| Disease | Intrahepatic cholangiocarcinoma |
Characteristics
| Age | 64 years |
|---|---|
| Gender | Female |
| Morphology | Epithelial |
| Growth properties | Adherent |
Regulatory Data
| Citation | RBE (Cytion catalog number 305019) |
|---|---|
| Biosafety level | 1 |
| NCBI_TaxID | 9606 |
| CellosaurusAccession | CVCL_4896 |
Biomolecular Data
Handling
| Culture Medium | RPMI 1640, w: 2.0 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a) |
|---|---|
| Supplements | Supplement the medium with 10% FBS |
| Dissociation Reagent | Accutase |
| Subculturing | Remove the old medium from the adherent cells and wash them with PBS that lacks calcium and magnesium. For T25 flasks, use 3-5 ml of PBS, and for T75 flasks, use 5-10 ml. Then, cover the cells completely with Accutase, using 1-2 ml for T25 flasks and 2.5 ml for T75 flasks. Let the cells incubate at room temperature for 8-10 minutes to detach them. After incubation, gently mix the cells with 10 ml of medium to resuspend them, then centrifuge at 300xg for 3 minutes. Discard the supernatant, resuspend the cells in fresh medium, and transfer them into new flasks that already contain fresh medium. |
| Fluid renewal | 2 to 3 times per week |
| Freeze medium | As a cryopreservation medium, we use complete growth medium (including FBS) + 10% DMSO for adequate post-thaw viability, or CM-1 (Cytion catalog number 800100), which includes optimized osmoprotectants and metabolic stabilizers to enhance recovery and reduce cryo-induced stress. |
| Thawing and Culturing Cells |
|
| Incubation Atmosphere | 37°C, 5% CO2, humidified atmosphere. |
| Shipping Conditions | Cryopreserved cell lines are shipped on dry ice in validated, insulated packaging with sufficient refrigerant to maintain approximately −78 °C throughout transit. On receipt, inspect the container immediately and transfer vials without delay to appropriate storage. |
| Storage Conditions | For long-term preservation, place vials in vapor-phase liquid nitrogen at about −150 to −196 °C. Storage at −80 °C is acceptable only as a short interim step before transfer to liquid nitrogen. |
Quality Control & Molecular Analysis
| Sterility | Mycoplasma contamination is excluded using both PCR-based assays and luminescence-based mycoplasma detection methods. To ensure there is no bacterial, fungal, or yeast contamination, cell cultures are subjected to daily visual inspections. |
|---|
Certificate of Analysis (CoA)
| Lot Number | Certificate Type | Date | Catalog Number |
|---|---|---|---|
| 305019-130123 | Certificate of Analysis | 23. May. 2025 | 305019 |
| 305019-020724 | Certificate of Analysis | 23. May. 2025 | 305019 |
| 305019-020326 | Certificate of Analysis | 08. Apr. 2026 | 305019 |
Material Transfer Agreement
If you intend to use Cytion cell lines solely for internal research at a single research site, please complete and sign our Material Transfer Agreement (MTA) and submit it along with your order.
For any commercial applications - including but not limited to fee-for-service work, quality control testing, product release, diagnostic use, or regulatory studies - please complete the Intended Use Form so we can prepare a suitable agreement tailored to your project.
Please note: The MTA applies only to certain cell lines. If this notice and the MTA document appear on a product page, the agreement is applicable. For cell lines not covered by the MTA, no reference to the agreement will be shown. The MTA is not valid for customers in the Americas, China, or Taiwan. Please contact our U.S. entity to receive the appropriate agreement.